Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Annals of Clinical Biochemistry|April 21, 2022
Validation of the Martin method to estimate low-density lipoprotein cholesterol concentrations in Japanese populations and a modified method for laboratory information system applicationHidekazu Ishida, Yasuko Yamamoto, Midori Saito, et al.
Human Molecular Genetics|October 4, 2023
Isogenic pairs of induced-pluripotent stem-derived endothelial cells identify DYRK1A/PPARG/EGR1 pathway is responsible for Down syndrome-associated pulmonary hypertensionHidehiro Suginobe, Hidekazu Ishida, Yoichiro Ishii, et al.
JTCVS Open|May 4, 2026
Clinical outcomes of pediatric heart transplantation: A 25-year follow-up experience in a Japanese instituteJun Narita, Ryo Ishii, Atsuko Kato, et al.
Pediatric Transplantation|April 28, 2025
Precision Monitoring of Immunosuppressive Agent Concentrations in Cardiac Tissue of Pediatric Heart Transplant RecipientsKazuhisa Hashimoto, Natsuka Kimura, Jun Narita, et al.
Plos One|September 29, 2022
Atomic force microscopy identifies the alteration of rheological properties of the cardiac fibroblasts in idiopathic restrictive cardiomyopathyMizuki Matsumoto, Hirofumi Tsuru, Hidehiro Suginobe, et al.
Plos One|August 8, 2012
An overgrowth disorder associated with excessive production of cGMP due to a gain-of-function mutation of the natriuretic peptide receptor 2 geneKohji Miura, Noriyuki Namba, Makoto Fujiwara, et al.
American Heart Journal Plus : Cardiology Research and Practice|April 24, 2026
Mid-term prognosis and risk stratification in patients with post-operative pulmonary hypertension: Insights from the Japanese Association of Congenital Heart Disease Registry (JACPHR)Naofumi F Sumitomo, Taku Ishii, Keiko Uchida, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|February 15, 2021
Cardiac Fibroblasts Play Pathogenic Roles in Idiopathic Restrictive CardiomyopathyHirofumi Tsuru, Hidekazu Ishida, Jun Narita, et al.
The American Journal of Cardiology|August 8, 2025
Pharmacological Treatment Practices for Patients With Congenital Heart Disease and Pulmonary Hypertension in Japan: Insights from the Japanese Association of Congenital Heart Disease Registry (JACPHR)Taku Ishii, Keiko Uchida, Susumu Hosokawa, et al.
Frontiers in Immunology|October 15, 2019
Fluctuations of Spleen Cytokine and Blood Lactate, Importance of Cellular Immunity in Host Defense Against Blood Stage Malaria Plasmodium yoeliiTakashi Imai, Kazutomo Suzue, Ha Ngo-Thanh, et al.
Pageof 8